• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . An integrative viro-bacterial signature based on viral load and high-resolution microbiome profiling predicts COVID-19 mortality

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2025 Dec:161:108153.
doi: 10.1016/j.ijid.2025.108153. Epub 2025 Oct 24.
An integrative viro-bacterial signature based on viral load and high-resolution microbiome profiling predicts COVID-19 mortality

Zi-Lun Lai[SUP] 1 [/SUP], Yang-Di Su[SUP] 1 [/SUP], Yi-Yao Hsu[SUP] 1 [/SUP], Yuan-Hua Hung[SUP] 1 [/SUP], Yuan-Yu Liu[SUP] 1 [/SUP], Yi-An Tai[SUP] 1 [/SUP], Hsiu-Hsien Lin[SUP] 1 [/SUP], Hung-Chieh Su[SUP] 2 [/SUP], Hong-Mo Shih[SUP] 3 [/SUP], Mao-Wang Ho[SUP] 2 [/SUP], Der-Yang Cho[SUP] 4 [/SUP], Po-Ren Hsueh[SUP] 5 [/SUP]


Affiliations
Abstract

Background: The nasopharyngeal (NP) microbiota may play a critical role in modulating host immune responses during SARS-CoV-2 infection, yet its utility for predicting clinical outcomes is not fully defined. We aimed to determine if an integrative approach, combining NP microbial profiles with virological and clinical data, could improve mortality prediction in COVID-19 patients.
Methods: We analyzed nasopharyngeal swabs from 81 COVID-19 patients and 70 non-infected controls. Full-length 16S rRNA sequencing was used for microbiome profiling. Predictive models were developed using machine learning to integrate microbial taxa with viral load and other clinical metadata.
Results: High viral load was identified as the strongest independent predictor of mortality by multivariate logistic regression (OR: 3.80). SARS-CoV-2 infection and its associated viral load were linked to significant reductions in microbial community evenness. Critically, a machine-learning model that integrated viral load, patient age, and specific microbial taxa achieved a high predictive accuracy for mortality (AUC = 0.9046), significantly outperforming models based on clinical data alone.
Conclusions: Our findings demonstrate that an integrative approach, combining nasopharyngeal microbiota profiles with viral load, provides a robust framework for predicting mortality in COVID-19 patients. This strategy offers a promising, non-invasive tool for improving clinical risk stratification.

Keywords: COVID-19; Full-length 16S rRNA sequencing; Mortality prediction; Nasopharyngeal microbiota; Predictive modeling; Viral load.

 
Back
Top